Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$9.91B |
| 2 |
SPCX
SpaceX
SPCX
|
+$871M |
| 3 |
Eli Lilly
LLY
|
+$719M |
| 4 |
Amazon
AMZN
|
+$698M |
| 5 |
Netflix
NFLX
|
+$627M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$3B |
| 2 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$1.54B |
| 3 |
TSMC
TSM
|
+$1.42B |
| 4 |
NVIDIA
NVDA
|
+$1.41B |
| 5 |
SNDK
Sandisk
SNDK
|
+$771M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 82.67% |
| 2 | Technology | 3.92% |
| 3 | Healthcare | 2.55% |
| 4 | Industrials | 2.24% |
| 5 | Financials | 2.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
CALL
Bank of Montreal
BMO
$121B
| $24M | ﹤0.01% |
135,600
-24,100
| -15% | -$3.79M |
|
2302
QuantumScape Corp
QS
$3.18B
| $23.9M | ﹤0.01% |
3,167,859
-1,251,784
| -28% | -$9.39M |
|
2303
CALL
Molina Healthcare
MOH
$10.7B
| $23.9M | ﹤0.01% |
104,700
+23,400
| +29% | +$4.24M |
|
2304
Essex Property Trust
ESS
$17.4B
| $23.9M | ﹤0.01% |
82,041
-234,823
| -74% | -$63.1M |
|
2305
Howard Hughes
HHH
$3.68B
| $23.9M | ﹤0.01% |
+334,562
| New | +$21.8M |
|
2306
Zymeworks
ZYME
$1.97B
| $23.9M | ﹤0.01% |
914,136
-235,882
| -21% | -$5.99M |
|
2307
CALL
Five Below
FIVE
$13B
| $23.9M | ﹤0.01% |
132,800
+59,900
| +82% | +$12.9M |
|
2308
PUT
BHP
BHP
$220B
| $23.9M | ﹤0.01% |
286,400
-21,900
| -7% | -$1.82M |
|
|
MRSH
2309
CALL
Marsh
MRSH
$83.3B
| $23.8M | ﹤0.01% |
143,000
+30,400
| +27% | +$5.08M |
|
2310
PUT
Moody's
MCO
$80B
| $23.8M | ﹤0.01% |
52,600
-37,000
| -41% | -$16.6M |
|
2311
CALL
Sysco
SYY
$37.9B
| $23.8M | ﹤0.01% |
284,900
-130,000
| -31% | -$9.84M |
|
2312
CALL
DuPont de Nemours
DD
$17.3B
| $23.8M | ﹤0.01% |
175,267
-135,600
| -44% | -$19.3M |
|
2313
PUT
Chewy
CHWY
$8.4B
| $23.8M | ﹤0.01% |
1,209,600
+243,300
| +25% | +$5.52M |
|
2314
Rockwell Automation
ROK
$45.5B
| $23.8M | ﹤0.01% |
47,991
-123,790
| -72% | -$53.9M |
|
2315
Jefferies Financial Group
JEF
$11B
| $23.7M | ﹤0.01% |
474,843
-216,012
| -31% | -$11.1M |
|
2316
CALL
Sarepta Therapeutics
SRPT
$2.18B
| $23.7M | ﹤0.01% |
1,320,400
+15,700
| +1% | +$297K |
|
2317
PUT
State Street SPDR S&P Bank ETF
KBE
$1.53B
| $23.7M | ﹤0.01% |
347,800
-86,000
| -20% | -$5.51M |
|
2318
Iris Energy
IREN
$17.1B
| $23.7M | ﹤0.01% |
518,526
-1,246,988
| -71% | -$64.8M |
|
2319
PUT
Bitdeer Technologies
BTDR
$3.05B
| $23.7M | ﹤0.01% |
1,490,900
+966,500
| +184% | +$13.9M |
|
2320
CALL
Franco-Nevada
FNV
$51.4B
| $23.7M | ﹤0.01% |
113,500
-20,900
| -16% | -$4.87M |
|
2321
CALL
Mettler-Toledo International
MTD
$28.3B
| $23.6M | ﹤0.01% |
18,500
+2,200
| +13% | +$2.65M |
|
2322
PUT
Direxion Daily GOOGL Bull 2X ETF
GGLL
$1.04B
| $23.6M | ﹤0.01% |
207,400
-114,100
| -35% | -$13.7M |
|
2323
Brookfield Renewable
BEPC
$5.54B
| $23.6M | ﹤0.01% |
634,999
+618,893
| +3,843% | +$24M |
|
|
2324
Franco-Nevada
FNV
$51.4B
| $23.5M | ﹤0.01% |
112,927
-126,294
| -53% | -$29.4M |
|
2325
PUT
Viking Therapeutics
VKTX
$3.42B
| $23.5M | ﹤0.01% |
603,200
+174,900
| +41% | +$5.65M |
|
Similar funds
Citadel Advisors's Q2 2026 Portfolio in Review
As of Q2 2026, Citadel Advisors held 15,445 positions worth $875B, up 41% from $618B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Citadel Advisors's Q2 2026 filing shows 2,573 new, 6,088 increased, 4,803 reduced and 1,873 closed positions. Its largest new stake was SpaceX: 5,129,884 shares worth $876M. The largest sale was Micron Technology, an estimated $3B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 79% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q2 2026 buy was SpaceX: 5,129,884 shares worth $876M.
- Citadel Advisors added most to iShares Core S&P 500 ETF in Q2 2026, an estimated $9.91B increase.
- Citadel Advisors's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $3B.
- Citadel Advisors fully exited iShares 7-10 Year Treasury Bond ETF in Q2 2026, selling an estimated $325M.
- Citadel Advisors's ten largest holdings make up 23% of its $875B portfolio in Q2 2026.
- Citadel Advisors opened 2,573 new positions and closed 1,873 in Q2 2026.
- Citadel Advisors's portfolio value rose 41% quarter-over-quarter to $875B.
Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.